"This is to be separated from what PPHM gets out of the trial, never the less, that will speed up things in future and work towards better clinical trial design (biomarker usage) and apart from the fact that Sunrise demonstrated again that bavituximab works (even though not approved for trial regulation reasons)."
Was this their goal going into the trial or was their goal to get FDA approval?